መነሻ › የክሮን በሽታ › New York › New York City
በNew York City፣ NY ለየክሮን በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየክሮን በሽታ የሚደረጉ 35 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- New York Gastroenterology Associates ( Site 0253), New York
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
- Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
- New York Gastroenterology Associates ( Site 5013), New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ተሳታዮችን በመፈለግ ላይደረጃ 4
- New York Gastroenterology Associates, New York
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Northwell Health-Lenox Hill Hospital /ID# 265527, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- New York Gastroenterology Associates, New York
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Weill Cornell Medical College, New York
- Lenox Hill Hospital, New York
- እና 1 ተጨማሪ
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ተሳታዮችን በመፈለግ ላይደረጃ 3
- New York Gastroenterology Associates, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Manhattan Clinical Research, LLC-Site Number: 8400069, New York
- NYU Langone Health-Site Number: 8400091, New York
- Columbia University Medical Center-Site Number: 8400138, New York
- እና 2 ተጨማሪ
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
- New York Gastroenterology Associates-Site Number: 8400009, New York
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Icahn School of Medicine at Mount Sinai /ID# 254880, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 4
- NYU Langone Health, New York
Standardized Microbiota Transplant Therapy in Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- NYU Langone Health, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- New York Gastroenterology Associates, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Weill Cornell Medicine, New York
Behavioral Therapy for Crohn's Disease
ተሳታዮችን በመፈለግ ላይ
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
ተሳታዮችን በመፈለግ ላይ
- NYU Langone Health, New York
- Cornell University, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Icahn School of Medicine at Mount Sinai, New York
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Icahn School of Medicine at Mount Sinai /ID# 262216, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- New York Presbyterian Hospital, New York
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Columbia University Medical Center, New York-Presbyterian Hospital, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Columbia University Medical Center, New York
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
ተሳታዮችን በመፈለግ ላይ
- Weill Cornell Medical College, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mirador Therapeutics Selected Site, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Icahn School of Medicine at Mount Sinai, New York
Treatment of Moderate to Severe Refractory Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Mount Sinai Health Systems, New York
Helmsley 3.0: Abbreviated MRE
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- NYU Langone, New York
በሌሎች ከተሞች ለየክሮን በሽታ የሚደረጉ ጥናቶች
- Boston, MA19 ጥናቶች
- Miami, FL19 ጥናቶች
- Cleveland, OH19 ጥናቶች
- St. Louis, MO19 ጥናቶች
- Tyler, TX17 ጥናቶች
- Houston, TX17 ጥናቶች
- Orlando, FL17 ጥናቶች
- Atlanta, GA17 ጥናቶች
- San Antonio, TX15 ጥናቶች
- San Diego, CA15 ጥናቶች
- Los Angeles, CA15 ጥናቶች
- Colorado Springs, CO13 ጥናቶች
በNew York City ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር136 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር121 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)109 ጥናቶች
- የፕሮስቴት ካንሰር103 ጥናቶች
- Metastatic Cancer93 ጥናቶች
- የኮሎሬክታል ካንሰር78 ጥናቶች
- የእንቁላል ካንሰር69 ጥናቶች
- የሳንባ ካንሰር60 ጥናቶች
- Multiple Myeloma60 ጥናቶች
- የፓንክሪያስ ካንሰር60 ጥናቶች
- የኤንዶሜትሪየም ካንሰር52 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ51 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።